The quiet rise of K18—a premium haircare brand with a scientific soul—offers a textbook case of what modern consumers want, and what luxury brands must now deliver. Not louder claims. Not flashier ...

The board of directors of Rossari Biotech Limited have recommended Final Dividend of 25% (i.e. Re. 0.50/- per share) on ...

The Board of Directors of Rossari Biotech Limited, at its meeting held today have approved the financial results of the ...

Studio TOOJ's illusory Duk furniture series features hard, unmoving forms that look like draped cloth but are made of wood ...

SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional ...

09:38 EDT Portage Biotech (PRTG) trading halted, volatility trading pause Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search ...

Or, maybe, it's just a grey wolf with a few tweaks. American biotech company Colossal Biosciences made a surprise announcement Monday, claiming it had brought the dire wolf back from the dead ...

America must invest at least $15 billion over the next five years to support its domestic biotechnology sector if it doesn’t want to lose to China, warns a national security commission made up ...

However, the prospect of future industry-specific tariffs could intensify selling pressure on biotech stocks. Despite the uncertainty, top hedge fund managers have invested millions of dollars in ...

Stainless Steel sales volumes grow 13% YoY and drop 23% MoM to 6,619 MT Stainless Steel average realisations increase 1% YoY and decline 1% MoM to Rs 1.28 lakh per MT Aluminium foil sales volumes ...

The U.S.-based biotechnology company is also known for its ambitious goal of bringing back the extinct woolly mammoth by 2028. This dire wolf pup is among the first of its species born in around ...

After a tough period of layoffs and hiring freezes, many were hoping 2025 would bring some relief to the biotech job market. But so far, that rebound hasn’t quite arrived. From cautious employers to ...